Browsing Tag
biological e
Biological E. to invest ₹1,800 crore in Hyderabad’s Genome Valley
Vaccine maker Biological E. will be investing ₹1,800 crore on expansion projects at three of its facilities in Genome Valley, Hyderabad.It is primarily to ramp up manufacturing of vaccines along with generic injectables and research and…
Corbevax gets nod from DGCI as heterologous Covid-19 booster
Biological E’s corbevax has become the first vaccine in India to get regulatory approval for a heterologous Covid-19 booster shot. People who are 18 years and above and have already taken two doses of either Covishield or Covaxin can now…
DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group
India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, official sources said…
Biological E to get mRNA technology from WHO to produce Covid-19 vaccines
City-based vaccine maker Biological E. on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation.
A press release from BE Limited said the WHO’s Advisory…
Over 3 lakh doses of Covid vaccine given to children aged 12-14 years on day 1
The vaccination against COVID-19 in the age group of 12-14 years started on Wednesday with Biological E’s intramuscular vaccine Corbevax, two doses of which are to be administered 28 days apart. Over 3 lakh children between 12 and 14 years…
Covid vaccination of children in 12-14 age group begins tomorrow
The decision to start vaccination for the 12-14 age group was taken after due deliberations with scientific bodies, the health ministry said.
The government on Monday said Covid-19 vaccination of children in the age group of 12-14 years…
Biological E to make 100 m doses of Corbevax per month
The company said it has reached production levels of 75 million doses per month at present and would make 100 plus million doses per month from February 2022.
Hyderabad-based Biological E said on Tuesday that it would deliver the 300…
Covid-19 vaccine: Biological E gets DCGI nod for Phase 2/3 trials on kids, adults
“The approvals from the DCGI will encourage us to move forward and produce the Covid-19 vaccine to meet the country's vaccination needs. These approvals will help support subsequent filings with the World Health Organisation as well,” Bio E…